Iconocast Logo

Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

 

Recent News and Articles on the Keywords: 35,500 + web + iconocast  Related to the article below (Last Update: 8/5/2008)

Presstek Reports Second Quarter 2008 Profit; Operating Expenses ...
IT News Online, India - Aug 1, 2008
An archived web cast of this conference call will also be available on the "Investor Events Calendar" page of the company's web site, at . ...PRST
Asian Stocks Decline on Profit, Growth Concerns; Toyota Falls
Bloomberg - Jul 28, 2008
Hanjin, South Korea's largest shipping line, plunged 7 percent to 35500 won, the most since Jan. 30. Nippon Yusen KK, Japan's biggest shipping line, ...TM - SIN:C6L

MLive.com
More antlerless-deer hunting licenses available
MLive.com, MI - Jul 11, 2008
That is a drop from 10200 and 35500 respectively in 2007. Lower Peninsula hunters will have more antlerless licenses available than last year. ...
Satış baskısıyla a?ılan Borsa, toparlanmayı bildi
My Net Haber, Turkey - Jul 10, 2008
A?ılışta 35105 puana kadar gevşeyen Ulusal 100 Endeksi, bir miktar tepki alımı ile 35706 puana kadar y?kseldikten sonra, 35500 civarında yatay seyre girdi ...
Source: Google News

[PDF] Design and Implementation of a Web-based Financial Information System -
JC Watt - 2004 - etd.ils.unc.edu
... Design and Implementation of a Web-based Financial Information System. ... This paper
describes the design and initial implementation of a web-based financial ...
-

Investigation of web stresses in reinforced concrete beams -
FE Richart - ideals.uiuc.edu
... 6 fto 295./ C \omprew5ss/ 2953 44.6's Tesioo in /? Sxeel ^2 0,.SI, "%^ "fl ' D7
5^ L^^ ^^e -T Fm 6"/7> WEB STRESSES IN ... 65 lj"be/-up 05S 35500 39500 274 466 ...

[PDF] … Accumulation of Polychlorinated Biphenyl Congeners in the Terrestrial Food Web of the Kalamazoo … -
AL Blankenship, MJ Zwiernik, KK Coady, DP Kay, JL … - Environmental Science & Technology, 2005 - msu.edu
Differential Accumulation of Polychlorinated Biphenyl Congeners in the Terrestrial
Food Web of the ... This study focused on two locations for food web analysis. ...

Infomaster: an information integration system -
MR Genesereth, AM Keller, OM Duschka - Proceedings of the 1997 ACM SIGMOD international conference …, 1997 - portal.acm.org
... SO, SQL databases through ODBC, EDI transactional and other World Wide Web (WW W ...
hlake Doors Seats Range MSRP 190e Mercedes 4 4 400 35500 450s1 Mercedes 2 2 336 ...

[PDF] A vacuuming-enhanced transaction-time web server -
Y Wang - 2006 - research.wsulibs.wsu.edu
Page 1. A VACUUMING-ENHANCED TRANSACTION-TIME WEB SERVER By Yingxia Wang ... iii Page
4. A VACUUMING-ENHANCED TRANSACTION-TIME WEB SERVER Abstract ...

Translating Implicit Information in the Light of Saussurean, Relevance, and Cognitive Theories
T Farrel, R Hoyle - Notes on Translation, 1995 - ethnologue.com
... Entry number, 35500. ...

HAEMOSTATIC CLIP HOLDER -
M Forster - EP Patent 0,926,991, 2002 - freepatentsonline.com
... than the height of the clip, and normally bearing against the web portion (52 ... generation.
Assignee: Vitalitec, International (13, rue Garengeot, Vitre, 35500, FR ...

[DOC] WEB DESTEKLI DERS ?ALISTIRICI TASARIMI
YDDHI B?LB?L, YDDI BATMAZ, YDDYG SAHIN, ?GM … - tojet.net
WEB DESTEKLI DERS ?ALISTIRICI TASARIMI. ... No:5 35500 Bornova IZMIR-TURKIYE Tel : +90
232 461 41 11(PBX) ext: 305 Fax : +90 232 461 41 21 e-mail: yasar.sahin ...

[CITATION] web GIs ? ??? ??? ??? ???? ????? ??
??

[PDF] Preparations of PAN-based Activated Carbon Nanofiber Web Electrode by Electrostatic Spinning and …
C Kim, JS Kim, WJ Lee, HS Kim, DD Edie, KS Yang - Journal of the Korean Electrochemical Society, 2002 - koixra1.kisti.re.kr
... asspun ? - h? (4] (? oxidativetystabIlized web. + Ae-E/RT (5) 70 ???? ...
????. 4001000 --11?? kkcc -- kkcc --aa SSCC 35500 30000 ...

Source: Google Scholar

Epiphany Biosciences Reports Initiation Of Phase 2 Study Of Valomaciclovir For The Treatment Of Acute Infectious Mononucleosis

 
Epiphany Biosciences announced, the initiation of a Phase 2 clinical trial with valomaciclovir (EPB-348) for the treatment and management of acute infectious mononucleosis. Currently, there are no approved therapeutics for the treatment for this debilitating condition or any other disease caused by the Epstein-Barr virus (EBV)

"Valomaciclovir has shown a broad spectrum of anti-viral activity, including inhibition of viral replication of herpes zoster and EBV," said Fred Volinsky, MD, Chief Executive Officer. "EBV has been implicated in a number of chronic and transplant-related diseases. This initial study in acute mononucleosis will set the stage for broader indications involving EBV as an etiologic agent. We are pleased to be working with the University of Minnesota on this important project".

"EBV is a highly prevalent virus, with up to 95% of middle-aged adults possessing evidence of viral exposure according to CDC surveillance data," stated Brian Murphy, MD, Chief Medical Officer. "Mononucleosis can severely undermine quality-of-life and the acute EBV infection may lead to other long-term medical sequelae. This double-blind, placebo-controlled, clinical trial will examine fluctuations in viral load as influenced by valomaciclovir as well as assess symptom scores."
"Our laboratory has found valomaciclovir to be a very potent anti-viral agent against EBV", reported Dr. Henry H. Balfour, Jr., Professor of Pediatrics and Laboratory Medicine and Pathology at the University of Minnesota, who is principal investigator for the study. "If this proof of concept study is successful, further large scale studies are warranted. We urgently need a solution for this disease that can severely impact the lives of young adults."

The acute mononucleosis study at the University of Minnesota will mark the first of several planned studies of valomaciclovir against EBV related diseases. Comparative anti-EBV potency data were presented by Professor Balfour's team at the annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC) in Chicago in September. A manuscript containing additional data confirming the unique susceptibility of EBV to valomaciclovir will be submitted to a peer-reviewed scientific journal shortly.

About Epiphany Biosciences

Epiphany Biosciences is focused on advancing new therapies for infectious disease. Epiphany is currently conducting a large Phase 2b study examining the safety and efficacy of valomaciclovir against herpes zoster infection.

Epiphany Biosciences Inc.
http://www.epiphanybio.com
 
 
 
Google
Web www.iconocast.com

Search inside Iconocast for the keyword you have in mind.

Iconocast has collected more than 50,000 articles and press releases on health and science.

These are current and most up to date press releases on the subject you are searching.

We collect current health and science press releases daily from more than 5000 research and health institutes. Here is an example : The elderberry way to perfect skin

We believe if you do search inside Iconocast, you will get better results than searching the web alone.

 
 
Continue News With: News7 ; News8 ; News9 ; News9A


ADVERTISEMENT

Iconocast is about learning and teaching without borders; we offer eMarketing, Internet Advertising, Internet Marketing, Search Engine Optimization, Search Engine Marketing, Online Branding, and eMarketing News Services.

 

Iconocast Home Page

Contact Iconocast

© 2003-07. ICONOCAST is a trademark of iconocast.com.